Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes.

Park C, Dietrich MS, Larsen B, Mayberry LS, Doyle A, Ahn S, Jean J, Maquiling K, Mogos MF, Muchira JM, Mulvaney S

Open source

DOI
10.2196/56497
Published
2026 Aug 25
Container
JMIR mHealth and uHealth
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2196/56497,
  title = {Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes.},
  author = {Park C and Dietrich MS and Larsen B and Mayberry LS and Doyle A and Ahn S and Jean J and Maquiling K and Mogos MF and Muchira JM and Mulvaney S},
  year = {2026},
  journal = {JMIR mHealth and uHealth},
  doi = {10.2196/56497},
  url = {https://doi.org/10.2196/56497}
}

RIS

TY  - JOUR
TI  - Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes.
AU  - Park C
AU  - Dietrich MS
AU  - Larsen B
AU  - Mayberry LS
AU  - Doyle A
AU  - Ahn S
AU  - Jean J
AU  - Maquiling K
AU  - Mogos MF
AU  - Muchira JM
AU  - Mulvaney S
PY  - 2026
JO  - JMIR mHealth and uHealth
DO  - 10.2196/56497
UR  - https://doi.org/10.2196/56497
ER  - 

APA

C, P., MS, D., B, L., LS, M., A, D., S, A., J, J., K, M., MF, M., JM, M., & S, M. (2026). Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes.. JMIR mHealth and uHealth. https://doi.org/10.2196/56497

Source records